223 related articles for article (PubMed ID: 25618349)
1. Principal component analysis as a tool for library design: a case study investigating natural products, brand-name drugs, natural product-like libraries, and drug-like libraries.
Wenderski TA; Stratton CF; Bauer RA; Kopp F; Tan DS
Methods Mol Biol; 2015; 1263():225-42. PubMed ID: 25618349
[TBL] [Abstract][Full Text] [Related]
2. Developing a drug-like natural product library.
Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
[TBL] [Abstract][Full Text] [Related]
3. Natural products as lead structures: chemical transformations to create lead-like libraries.
Pascolutti M; Quinn RJ
Drug Discov Today; 2014 Mar; 19(3):215-21. PubMed ID: 24171951
[TBL] [Abstract][Full Text] [Related]
4. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries.
Lee ML; Schneider G
J Comb Chem; 2001; 3(3):284-9. PubMed ID: 11350252
[TBL] [Abstract][Full Text] [Related]
5. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
Newman DJ
J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
[No Abstract] [Full Text] [Related]
6. Characterization of the Chemical Space of Known and Readily Obtainable Natural Products.
Chen Y; Garcia de Lomana M; Friedrich NO; Kirchmair J
J Chem Inf Model; 2018 Aug; 58(8):1518-1532. PubMed ID: 30010333
[TBL] [Abstract][Full Text] [Related]
7. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.
Feher M; Schmidt JM
J Chem Inf Comput Sci; 2003; 43(1):218-27. PubMed ID: 12546556
[TBL] [Abstract][Full Text] [Related]
8. Cheminformatic comparison of approved drugs from natural product versus synthetic origins.
Stratton CF; Newman DJ; Tan DS
Bioorg Med Chem Lett; 2015 Nov; 25(21):4802-4807. PubMed ID: 26254944
[TBL] [Abstract][Full Text] [Related]
9. The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery.
Barnes EC; Kumar R; Davis RA
Nat Prod Rep; 2016 Mar; 33(3):372-81. PubMed ID: 26739749
[TBL] [Abstract][Full Text] [Related]
10. A minimalist fragment approach for the design of natural-product-like synthetic scaffolds.
Genis D; Kirpichenok M; Kombarov R
Drug Discov Today; 2012 Nov; 17(21-22):1170-4. PubMed ID: 22659098
[TBL] [Abstract][Full Text] [Related]
11. Natural product-likeness score and its application for prioritization of compound libraries.
Ertl P; Roggo S; Schuffenhauer A
J Chem Inf Model; 2008 Jan; 48(1):68-74. PubMed ID: 18034468
[TBL] [Abstract][Full Text] [Related]
12. Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository.
Singh N; Guha R; Giulianotti MA; Pinilla C; Houghten RA; Medina-Franco JL
J Chem Inf Model; 2009 Apr; 49(4):1010-24. PubMed ID: 19301827
[TBL] [Abstract][Full Text] [Related]
13. BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery.
Kombarov R; Altieri A; Genis D; Kirpichenok M; Kochubey V; Rakitina N; Titarenko Z
Mol Divers; 2010 Feb; 14(1):193-200. PubMed ID: 19468851
[TBL] [Abstract][Full Text] [Related]
14. Capturing nature's diversity.
Pascolutti M; Campitelli M; Nguyen B; Pham N; Gorse AD; Quinn RJ
PLoS One; 2015; 10(4):e0120942. PubMed ID: 25902039
[TBL] [Abstract][Full Text] [Related]
15. Construction of a 3D-shaped, natural product like fragment library by fragmentation and diversification of natural products.
Prescher H; Koch G; Schuhmann T; Ertl P; Bussenault A; Glick M; Dix I; Petersen F; Lizos DE
Bioorg Med Chem; 2017 Feb; 25(3):921-925. PubMed ID: 28011199
[TBL] [Abstract][Full Text] [Related]
16. The design, synthesis, and anti-inflammatory evaluation of a drug-like library based on the natural product valerenic acid.
Egbewande FA; Nilsson N; White JM; Coster MJ; Davis RA
Bioorg Med Chem Lett; 2017 Jul; 27(14):3185-3189. PubMed ID: 28558967
[TBL] [Abstract][Full Text] [Related]
17. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type.
Torre BG; Albericio F
Molecules; 2017 Feb; 22(3):. PubMed ID: 28264468
[TBL] [Abstract][Full Text] [Related]
18. Expanding the medicinally relevant chemical space with compound libraries.
López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
[TBL] [Abstract][Full Text] [Related]
19. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
Dobson PD; Patel Y; Kell DB
Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
[TBL] [Abstract][Full Text] [Related]
20. Charting, navigating, and populating natural product chemical space for drug discovery.
Lachance H; Wetzel S; Kumar K; Waldmann H
J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
